ArticleAnnals of surgical oncology2026

Editorial Comment: Rethinking Local Control in Stage IV EGFR-Mutant NSCLC: A Biologic Rationale for Primary Tumor Resection in the Era of Targeted Therapy.

Saki Tsubouchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.